Navigation Links
Jazz Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
Date:3/16/2010

PALO ALTO, Calif., March 16 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Robert Myers, the company's President, will present at the Barclays Capital 2010 Global Healthcare Conference on Wednesday, March 24, 2010 at 8:00 a.m. Eastern Time at The Loews Miami Hotel in Miami, Florida.

After the presentation, the slides may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. The slides will be available for two weeks following the presentation.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry.  For further information see www.JazzPharmaceuticals.com.

SOURCE Jazz Pharmaceuticals, Inc.

Back to top

RELATED LINKS
http://www.jazzpharmaceuticals.com

'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Astellas Responds to OSI Pharmaceuticals Rejection
2. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2009 Financial Results
3. Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium
4. Anthera Pharmaceuticals Completes Initial Public Offering
5. Biostar Pharmaceuticals, Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing
6. MAP Pharmaceuticals Reports 2009 Fourth Quarter and Year End Financial Results
7. Alexza Pharmaceuticals to Present at the Cowen and Company 30th Annual Health Care Conference
8. DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Call
9. Thomas Pharmaceuticals, Ltd to Merge with Global Medical Equipment of AZ
10. Abbott Completes Acquisition of Solvay Pharmaceuticals
11. Biostar Pharmaceuticals, Inc. Announces Change of Auditor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
(Date:5/26/2016)... ... 26, 2016 , ... American orthopedic surgeon and internationally recognized ... Horizon International (BHI), Brian Mehling, M.D., spoke at an International Conference and Expo ... in Chicago, IL, USA. Dr. Mehling’s presentation was focused on stem cell therapy ...
(Date:5/26/2016)... TN (PRWEB) , ... May 26, 2016 , ... ... fitness education and products recently hosted the first PowerWave Instructor Certification Course in ... who lead a group of fitness professional through the 8 hour interactive course ...
(Date:5/26/2016)... ... 2016 , ... On May 23rd during the National Eye Institute’s “Healthy Vision ... advocate, was honored by Ashram, Inc. as the world’s foremost water visionary. , “Sharon ... banks of the Nile to fill their red clay pots with life-sustaining water.” Said ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite Ergonomics ... leadership and to further develop their rapidly expanding portfolio of customer and end ... a concentration in Marketing and an M.B.A. with concentration in management from Bryant ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... Frankfurt Prime Standard: QIA) today announced that the company has ... GmbH to develop and commercialize predictive assays in oncology. An ... a marker to predict effectiveness of anthracycline treatment in triple ... are pleased to partner with Therawis, which developed the PITX2 ...
Breaking Medicine Technology: